Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Evoke Pharma (EVOK) over the last 4 years, with Q3 2025 value amounting to $6312.0.

  • Evoke Pharma's Other Non-Current Assets fell 9453.45% to $6312.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6312.0, marking a year-over-year decrease of 9453.45%. This contributed to the annual value of $120614.0 for FY2024, which is 5008.46% down from last year.
  • As of Q3 2025, Evoke Pharma's Other Non-Current Assets stood at $6312.0, which was down 9453.45% from $6312.0 recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Other Non-Current Assets registered a high of $241637.0 during Q4 2023, and its lowest value of $6312.0 during Q1 2025.
  • Moreover, its 3-year median value for Other Non-Current Assets was $60900.0 (2024), whereas its average is $82779.2.
  • Per our database at Business Quant, Evoke Pharma's Other Non-Current Assets crashed by 5008.46% in 2024 and then plummeted by 9453.45% in 2025.
  • Quarter analysis of 3 years shows Evoke Pharma's Other Non-Current Assets stood at $241637.0 in 2023, then crashed by 50.08% to $120614.0 in 2024, then tumbled by 94.77% to $6312.0 in 2025.
  • Its Other Non-Current Assets was $6312.0 in Q3 2025, compared to $6312.0 in Q2 2025 and $6312.0 in Q1 2025.